Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03330561 |
Title | PRS-343 in HER2-Positive Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Pieris Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Arizona Cancer Center | Tucson | Arizona | 85719 | United States | Details | |
University of California Los Angeles (UCLA) | Santa Monica | California | 90404 | United States | Details | |
Georgetown University, Lombardi Comprehensive Cancer Center | Washington | District of Columbia | 20007 | United States | Details | |
Johns Hopkins University School of Medicine | Baltimore | Maryland | 21287 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
University of Pittsburgh Medical Center (UPMC) | Pittsburgh | Pennsylvania | 15213 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
M.D. Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
START - South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | United States | Details |